Related Experiment Video
Updated: Jan 28, 2026

Derivation and Differentiation of Canine Ovarian Mesenchymal Stem Cells
Published on: December 16, 2018
The road less travelled: The efficacy of canine pluripotent stem cells
Dhanya V Menon1, Darshan Patel2, Chaitanya G Joshi3
1P.D.Patel Institute of Applied Sciences, Charusat University, Changa, Gujarat, India; School of Regenerative Medicine (SORM), Manipal Academy of Higher Education, Bangalore, India.
Abstract:
The path-breaking discovery of induced pluripotent stem cells has fuelled the scientific advancements of stem cells. Nevertheless, the need to ensure the safety of stem cell therapy at translational level is still at large, prompting scientists to use animal models which are genetically and anatomically homologous to that of humans. Dogs, being genomically and physiologically more similar to humans serve as better models in mimicking human diseases as compared to rodents. The heterogeneity in canine breeds offers an excellent opportunity to comprehend the complexities of many genetic diseases, making them exceptional tools for stem cell therapies. Various canine gene therapy models have paved the foundation for strategizing therapies for humans. But a similar progress is lacking in utilizing canine stem cells for stem cell-based therapies in both dogs and humans. This review attempts to bridge the gap, by articulating the key differences in canine pluripotency pathways, based on the recent derivation of canine embryonic stem cells (cESCs) and canine induced pluripotent stem cells (ciPSCs), thereby attempting to position dog in the reprogramming landscape. The potential clinical application of canine iPSCs also offers great hope to canine patients and might lead to significant contributions in veterinary medicine.
Insights
Canine stem cells, including embryonic stem cells (cESCs) and induced pluripotent stem cells (ciPSCs), show promise for regenerative medicine. This review highlights their potential in both veterinary and human therapies by examining canine pluripotency pathways.
Area of Science:
- Stem cell research
- Regenerative medicine
- Comparative genomics
Background:
- Induced pluripotent stem cells (iPSCs) have advanced stem cell research.
- Ensuring stem cell therapy safety requires suitable animal models.
- Dogs are valuable models due to genomic and physiological similarity to humans.
Purpose of the Study:
- To review canine pluripotency pathways.
- To bridge the gap in utilizing canine stem cells for therapy.
- To position dogs within the reprogramming landscape.
Main Methods:
- Analysis of recent canine embryonic stem cell (cESC) and canine induced pluripotent stem cell (ciPSC) derivations.
- Comparison of canine pluripotency pathways.
- Review of existing canine gene therapy models.
Main Results:
- Dogs offer unique advantages for disease modeling and stem cell therapy research.
- Key differences in canine pluripotency pathways are identified.
- Canine iPSCs present significant therapeutic potential.
Conclusions:
- Canine stem cells hold great promise for veterinary and human medicine.
- Further research into canine pluripotency pathways is warranted.
- Canine iPSCs could revolutionize regenerative medicine in veterinary care.
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Travelling Waves
Water waves, sound waves, and seismic waves are some examples of mechanical waves. For water waves, the wave propagation medium is...
Embryonic Stem Cells
Traveling Waves: Lossless Lines
Design Example: Alignment of a Road Line Using GIS

